← Open Payments lookup

MING CHI: Open Payments

NPI 1902149016 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$946 in 60 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $946

Food & beverage: $946
CompanyPaymentsAmount
ABBVIE INC.18$227
Otsuka America Pharmaceutical, Inc.17$212
E.R. Squibb & Sons, L.L.C.6$101
Alkermes, Inc.4$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$87
Vanda Pharmaceuticals Inc.3$72
Neurocrine BioSciences, Inc.3$54
Teva Pharmaceuticals USA, Inc.2$46
Axsome Therapeutics, Inc.1$21
Janssen Pharmaceuticals, Inc1$15

Products named: VRAYLAR, ABILIFY ASIMTUFII, COBENFY, REXULTI, CAPLYTA, FANAPT, ARISTADA, INGREZZA.

Industry payments across MO — which companies pay providers there.